
To review and analyze the national disease strategies and identify gaps in information or evidence.
Review lessons learned from programming supported by or focusing on priorities of civil society and key populations.
Take stock of evidence available to justify programming focusing on KPs and other priority programming areas.
Review and analyze the changes relevant to CS in the new funding model and changes to CSS and clarify roles of the civil society in the NFM.
Identify appropriate partnerships and collaborations to manage ongoing work in the development of a robust and relevant funding proposal.
Develop an effective advocacy strategy for civil society constituents in the CCM and Global Fund board constituencies.
Improve understanding of the Investment Framework and how marginalized groups (including KPs) can act as critical enablers.